Testing the theory of immune selection in cancers that break the rules of transplantation Ariberto FassatiN. Avrion Mitchison Perspectives Open access 22 December 2009 Pages: 643 - 651
Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer Hiroyuki SuzukiNobuhito ChikazawaMitsuo Katano Original Article 12 November 2009 Pages: 653 - 661
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer James L. GulleyPhilip M. ArlenJeffrey Schlom Original Article 05 November 2009 Pages: 663 - 674
Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh Akio YamasakiChizu KamedaMitsuo Katano Original Article 28 October 2009 Pages: 675 - 686
Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting Matthias MaySabine Brookman-MayManfred Johannsen Original Article 30 October 2009 Pages: 687 - 695
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine Irina DaurkinEvgeniy EruslanovSergei Kusmartsev Original Article 31 October 2009 Pages: 697 - 706
A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector Weijun ZhangTong ZhangEdward J. Usherwood Original Article 17 November 2009 Pages: 707 - 713
Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy Eftychia LekkaAngelos D. GritzapisConstantin N. Baxevanis Original Article 11 November 2009 Pages: 715 - 727
TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model Nasreen VohraMonique VerhaegenShari Pilon-Thomas Original Article 17 November 2009 Pages: 729 - 736
Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin Robert SarnovskyTara TendlerDavid J. FitzGerald Original Article 29 November 2009 Pages: 737 - 746
Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2Kb-restricted T cell epitope Jung-Sun ParkHye-Sung KimTai-Gyu Kim Original Paper 20 November 2009 Pages: 747 - 757
EphA2-derived peptide vaccine with amphiphilic poly(γ-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor Shinjiro YamaguchiTomohide TatsumiNorio Hayashi Original Article 27 November 2009 Pages: 759 - 767
Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma Miki TonguNanae HarashimaMamoru Harada Original Article 26 November 2009 Pages: 769 - 777
Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function Chang-Xuan YouYong LiuPaul L. Hermonat Original Article 29 November 2009 Pages: 779 - 787
Activation of innate immunity to reduce lung metastases in breast cancer Julie L. JordanA. NowakT. D. G. Lee Original Article 03 December 2009 Pages: 789 - 797
Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3 Cornelia L. TrimbleShiwen PengT. C. Wu Short Communication 13 December 2009 Pages: 799 - 803